Biotricity is trading 12.25% up at $0.09, with the catalyst unclear.
- No company-specific announcement, filing, earnings release, FDA update, financing, partnership, or analyst action dated September 20–22, 2026 was identified.
- Biotricity’s newsroom lists no September 2026 releases.
- Broader markets are essentially mixed.